Chonluten
Also known as: Glu-Asp-Gly, EDG
Popular For
Respiratory health, lung function, bronchial support
Key Facts: Chonluten
- Category
- Bioregulators
- FDA Status
- Not FDA Approved
- Clinical Status
- Preclinical research, approved in Russia as supplement
- Administration
- Oral capsules or sublingual
- Typical Dose
- 10-20 mg daily
- Frequency
- Once or twice daily
- Evidence Level
- Preclinical
- Duration
- 10-30 day cycles
Mechanism of Action
Chonluten functions as a regulator of inflammatory and proliferative processes in lung and bronchial tissue. It modulates gene expression patterns specific to respiratory epithelium and mucosal tissues, supporting tissue regeneration and healthy function.
Research Summary
Research focuses on lung and bronchial tissue support. Studies show regulatory effects on inflammatory processes and cellular proliferation in respiratory systems. Part of the Khavinson synthesized peptide bioregulator family.
Dosing Information
Note: Animal study doses may not translate directly to humans.
Typical Dosingⓘ
Community experience
10-20 mg daily
10-20 mg daily
Once or twice daily
Lung tissue bioregulator. Khavinson peptide for respiratory support.
Research Dosingⓘ
Scientific studies
Doses from bioregulator supplement protocols
Doses from Studies
10-20 mg daily
Duration
10-30 day cycles
Administration
Oral capsules or sublingual
Timing & Administration
Best Time to Take
Morning on empty stomach
Once or twice daily
Food Recommendation
Take on empty stomach
Why This Timing?
Peptide bioregulators typically taken fasted for optimal absorption
Possible Side Effects
Not everyone experiences these effects. Individual responses vary based on dosage, duration, and personal factors.
- ●Generally well-tolerated
- ●Limited safety data outside Russia
- ●Not FDA approved
References
Related Peptides
Peptides commonly compared with Chonluten or used in similar applications.
Testagen
PreclinicalA peptide bioregulator targeting testicular tissue. Supports healthy testicular function through tissue-specific gene regulation. Part of the Khavinson peptide bioregulator family.
BioregulatorsBronchogen
PreclinicalA tetrapeptide bioregulator (Ala-Glu-Asp-Leu) targeting bronchial and respiratory tissue. Part of the Khavinson bioregulator family. Used for respiratory health support, bronchial conditions, and lung tissue regeneration.
BioregulatorsLivagen
PreclinicalA tetrapeptide bioregulator (Lys-Glu-Asp-Ala) developed by Khavinson that modulates chromatin structure and gene expression. Research shows it can decondense heterochromatin and activate ribosomal genes, potentially restoring more youthful gene expression patterns in aging cells.
BioregulatorsOvagen
PreclinicalA tripeptide bioregulator (Glu-Asp-Leu) targeting liver and gastrointestinal tissue. Derived from liver tissue extracts, Ovagen modulates gene expression related to detoxification, antioxidant defense, and hepatocellular repair.
BioregulatorsCortagen
PreclinicalA tetrapeptide bioregulator (Ala-Glu-Asp-Pro) derived from cerebral cortex extracts. Studied for neuroprotection, neural differentiation, and cognitive support. Regulates neurotrophic signaling and synaptic stability.
BioregulatorsVesugen
PreclinicalA tripeptide bioregulator (Lys-Glu-Asp) targeting vascular tissue. Promotes restoration of blood vessel tissues and normalization of vascular function. Stimulates endothelial cell proliferation markers.
BioregulatorsLooking for a trusted vendor?
Pro members get access to verified vendors with quality standards & exclusive discount codes.
Want updates on Chonluten research?
Subscribe to get notified when we add new research findings, protocol updates, and related peptide information.